|View printer-friendly version|
|December 07, 2005 11:59 a.m.|
|Teva Announces Final Approval of Oxycodone ER Tablets, 10 Mg, 20 Mg and 40 Mg|
Jerusalem, Israel, December 7, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Oxycodone Extended Release Tablets, 10 mg, 20 mg and 40 mg. Shipment will begin immediately.